Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BARD1 |
| Variant | Q730L |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | BARD1 Q730L lies within BRCT domain 2 of the Bard1 protein (UniProt.org). Q730L demonstrates Brca1, Palb2, and Rad51c interaction similar to wild-type Bard1, but results in altered Bard1 subcellular localization, impaired homology-directed DNA repair activity, decreased DNA repair post-irradiation, decreased H2A ubiquitination, and increased sensitivity to olaparib and cisplatin treatment in cultured cells (PMID: 39387837). |
| Associated Drug Resistance | |
| Category Variants Paths |
BARD1 mutant BARD1 inact mut BARD1 Q730L |
| Transcript | NM_000465.4 |
| gDNA | chr2:g.214728821T>A |
| cDNA | c.2189A>T |
| Protein | p.Q730L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000465.4 | chr2:g.214728821T>A | c.2189A>T | p.Q730L | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|